Роль лучевых методов в диагностике висцерального ожирения у пациентов с избыточной массой тела
![Диссертация: Роль лучевых методов в диагностике висцерального ожирения у пациентов с избыточной массой тела](https://westud.ru/work/2699579/cover.png)
Диссертация
В связи с этим, в последнее десятилетие интерес ученых был направлен на изучение возможности применения ультразвукового метода диагностики висцерального ожирения (ВО). Были предложены несколько способов измерения толщины ВЖТ: самым распространенным методом диагностики висцерального ожирения является сонографический, в основе которого лежит определение толщины абдоминального жира (расстояние между… Читать ещё >
Содержание
- ГЛАВА 1. ОБЗОР ЛИТЕРАТУРЫ
- 1. 1. Ожирение — актуальная проблема современного здравоохранения
- 1. 2. Современные клинико-патогенетические аспекты развития ожирения и метаболического синдрома
- 1. 3. Методы лучевой диагностики висцерального ожирения
- ГЛАВА 2. МАТЕРИАЛЫ И МЕТОДЫ ИССЛЕДОВАНИЯ
- 2. 1. Характеристика клинического материала и лабораторных методов исследования
- 2. 2. Характеристика методов лучевой диагностики
- ГЛАВА 3. РЕЗУЛЬТАТЫ СОБСТВЕННЫХ ИССЛЕДОВАНИЙ
- 3. 1. Клинические и гормонально-метаболические аспекты ожирения
- 3. 2. Результаты лучевого исследования пациентов с избыточной массой тела и ожирением
- 3. 2. 1. Компьютерно-томографическое исследование пациентов с ожирением по сравнению с контрольной группой
- 3. 2. 2. Магнитно-резонансное исследование у пациентов с избыточной массой тела и ожирением
- 3. 2. 3. Взаимосвязь показателей томографических методов диагностики с метаболическими и гормональными нарушениями у пациентов с избыточной массой тела
- 3. 2. 4. Сравнительная характеристика стандартного ультразвукового исследования у обследованных пациентов
- 3. 2. 5. Оценка количества предбрюшинного жира, измеренного ультразвуковым методом
- 3. 2. 6. Сравнительная оценка различных лучевых методов исследования жировой ткани в абдоминальной области
- 3. 2. 7. Анализ взаимосвязей показателей ультразвуковых методик с клинико-метаболическими и гормональными нарушениями у пациентов с ожирением
- 3. 2. 8. ШЭС-анализ различных лучевых методов исследования
Список литературы
- Алмазов В.А., Благосклонная Я. В., Шляхто Е. В. и др. Роль абдоминального ожирения в патогенезе синдрома инсулинорезистентности // Терапевт, арх. 1999. № 10. С. 20—24.
- Аметов A.C. ß--клетки поджелудочной железы — возвращение на центральную сцену // ß--клетка: секреция инсулина в норме и патологии. М., 2005. С. 12.
- Аметов A.C. Ожирение — эпидемия XXI века // Терапевт, арх.2002. Т. 74. № 10. С. 5—7.
- Анциферов М.Б. Исследование UKPDS и основные принципы пероральной терапии сахарного диабета 2 типа // Ожирение. Метаболический синдром. Сахарный диабет 2 типа. / Под ред. И. И. Дедова. М., 2000.С. 53−61.
- Балаболкин М.И., Клебанова Е. М., Креминская В. М. Дифференциальная диагностика и лечение эндокринных заболеваний: Руководство. М.: Медицина, 2002. 752 с.
- Бутрова С.А. Метаболический синдром: патогенез, клиника, диагностика, подходы к лечению // РЖЖ. 2001. Т. 9. № 2. С. 56—61.
- Бутрова С.А. Сибутрамин в лечении ожирения: опыт применения в России // Клинич. фармакология и терапия. 2001. № 2.С. 70—75.
- Гинзбург М.М., Крюков H.H. Ожирение. Влияние на развитие метаболического синдрома. Профилактика и лечение. М.: Медпрактика, 2002. 128 с.
- Дедов И.И. Ожирение. Метаболический синдром. Сахарный диабет: Методические рекомендации. М., 2000.
- Дедов И.И., Бутрова С. А., Дзгоева Ф. Х. Динамика факторов риска сахарного диабета 2 типа и сердечно-сосудистых заболеваний у больных с абдоминальным типом ожирения // Ожирение и метаболизм. 2004. № 2. С. 19—24.
- Дедов И.И., Мельниченко Г. А. Ожирение: этиология, патогенез, клинические аспекты. М.: Мед. информ. агентство, 2004. 456 с.
- Демидова И.Ю., Игнатова Н., Рейдне И. Метформин (сиофор): механизм действия и клиническое применение // Клинич. эндокринология. 1998. № 1. С. 3—27.
- Демидова Т.Ю. Борьба с ожирением — необходимое звено профилактики сахарного диабета 2 типа // Диабет. Образ жизни. 2005. № 6. С. 55—56.
- Демидова Т.Ю. Ожирение: проблемы и пути их решения // Диабет. Образ жизни. 2000. № 1. С. 36—37.
- Клебанова Е.М., Балаболкин М. И., Креминская В. М. Инсулинорезистентность: ее роль в патогенезе сахарного диабета 2 типа и возможности коррекции // Лечащий врач. 2005. № 5. С. 16—21
- Кравец, Е. Б. Алгоритмы амбулаторной эндокринологии: учеб. пособие / Е. Б. Кравец, В. А. Столярова, Г. И. Цыров, Ю. Г. Самойлова, В. Н. Латыпова и др. Томск, 2008. — 342 с.
- Кравец Е.Б., Самойлова Ю. Г., Матюшева Н. Б., Буланова A.A., Дорохова В. В., Ядмаа О. Метаболический синдром в общеврачебной практике // Бюллетень сибирской медицины. 2008. — № 1. — С. 80−87.
- Мамедов М.Н. Руководство по диагностике и лечению метаболического синдрома: Методические рекомендации. М., 2004. 72 с.
- Мельниченко Г. А. Ожирение в практике эндокринолога // Рос.мед. журн. 2001. Т. 9. № 2. С. 82—87.
- Мкртумян А.М. Роль липотоксичности в нарушении секреции инсулина и развитии инсулинорезистентности // ß--клетка: секреция инсулина в норме и патологии. М., 2005. С. 65—76.
- Мычка В.Б., Масенко В. П., Чазова И. Е. Артериальная гипертония на фоне избыточного веса: особенности терапевтического подхода // Ожирение и метаболизм. 2006. № 3 (8). С. 46—50.
- Научный симпозиум «Метаболический синдром. Новые подходы к лечению». //Кардиология. 2000. № 8. С. 77−80.
- Проблема ожирения в современном мире / Р. Кушнер, Д. Бессесен. М.: Бином, 2006. — 239 с.
- Рахимова, Г. Н. Оценка частоты метаболического синдрома среди пациентов, проживающих в Узбекистане / Г. Н. Рахимова, Ш. Ш. Азизова // Сб. тез. IV Всерос. диабетологического конгр. М., 2008. — С. 253.
- Роль абдоминального ожирения в развитии моторной дисфункции желчного пузыря при холестериновом холелитиазе / Н. А. Поляруш, И. В. Дворяшина, А. А. Мочалов, А. М. Эпштейн // Ожирение и метаболизм. -2007.-№ 2.-С. 39—41.
- Сорвачева Т.Н., Петеркова В. А., Титова J1.H. и др. Ожирение у подростков. Альтернативные подходы диетотерапии // Леч.врач. 2006. № 4. С. 50—54.
- Терещенко, И. В. Современные проблемы лечения ожирения / И. В. Терещенко // Проблемы эндокринологии. 2008. — № 3. — С. 57—61.
- Уирт А. Снижение массы тела и улучшение состояния у больных с ожирением после применения препарата ксеникал, XXL исследование в сети первичной медицинской помощи //Проблемы эндокринологии. 2006. № 3. С. 21—25.
- Чазова И.Е., Мычка В. Б. Метаболический синдром. М., 2004. 168 с.
- Чугунова Л.Г., Дубинина И. И. Состояние углеводного, липидного и гормонального статуса у больных с метаболическим синдромом // Сахарный диабет. 2001. № з. с. 44—48.
- Шестакова М.В. Дисфункция эндотелия — причина или следствие метаболического синдрома? // Рос. мед. журн. 2001. Т. 9.№ 2. С. 88—90.
- Abe Т, Kawakami Y, Sugita М, Yoshikawa К, Fukunaga Т. Use of B-mode ultrasound for visceral fat mass evaluation: comparisons with magnetic resonance imaging. //Appl Human Sci .1995. V.14. P. 133−139.
- Al-Lawati JA, Mohammed AJ, Al-Hinai HQ, Jousilahti P. Prevalence of the metabolic syndrome among Omani adults. Diabetes Care. 2003- 26: 1781−1785.
- American Diabetes Assocation. Standards of medical care in diabetes. Diabetes Care. 2005- 38: S4-S36.
- Anderson PJ, Chan JCN, Chan YL, Tomlinson B, Young RP, Lee ZS, Lee KK, Metreweli C, Cockram CS, Critchley JA. Visceral fat and cardiovascular risk factors in Chinese NIDDM patients. // Diabetes Care. 1997. V. 20 P. 1854−1858.
- Angelico F, Del Ben M, Conti R, Francioso S, Feole K, Fiorello S, Cavallo MG, Zalunardo B, Lirussi F, Alessandri C, Violi F. Insulin resistance, the metabolic syndrome and non-alcoholic fatty liver disease. J Clin Endocrinol Metab. 2005- 90: 1578−1582.
- Apridonidze T, Essah PA, Iuorno MJ, Nestler JE. Prevalence and characteristics of the metabolic syndrome in women with polycystic ovary syndrome. J Clin Endocrinol Metab. 2005- 90: 1929−1935.
- Armellini F, Zamboni M, Rigo L, Todesco T, Bergamo-Andreis IA, Procacci C, Bosello O. The contribution of sonography to the measurement of intra-abdominal fat.// J Clin Ultrasound. 1990. V.18. P.563−567.
- Armellini F, Zamboni M, Rigo L. Sonography detection of small intraabdominal fat variations.// Int J Obes. 1991. V. 15. P. 847−852.
- Armellini F, Zamboni M., Castelli S, Micciolo R, Mino A, Turcato E, Rigo L, Intraabdominal fat measurements by ultrasound and anthropometric measurements.// Int J Obes. 1995. V. 15. P. 209−214.
- Armellini F, Zamboni M, Robbi R, et al. Total and intra-abdominal fat measurements by ultrasound and computerized tomography. // Int J Obes. Relat Metab Disord .1993. V. 17. P. 209−214.
- Ashwell M, Cole TJ, Dixon AK. Obesity: new insight into the anthropometric classification of fat distribution shown by computed tomography. Br Med J (Clin Res Ed).1985. V.290. P.1692−1694.
- Baker AR, Silva NF, Quinn DW, et al. Human epicardial adipose tissue expresses a pathogenic profile of adipocytokines in patients with cardiovascular disease. //Cardiovasc Diabetol. 2006. V. 5.P.I.
- Balkau B, Charles MA. Comment on the provisional report from the WHO consultation. European Group for the Study of Insulin Resistance (EGIR). Diabet Med. 1999- 16: 442−443.
- Behavior therapy and sibutramine for the treatment of adolescents obesity: arandomized controlled trial / R. I. Berkowitz, T. A. Wadden, A. M. Tershakovec, J. L. Cronquist // JAMA. 2003. — Vol. 289, № 14. — P. 1805—1812.
- Barash J.A., Cheung C.E., Weigle D.S. et al. Leptin is a metabolic signal to the reproductive system // Endocrinology. 1996. V. 137. № 31. P. 44—47.
- Bellisari A. Reliability of B mode ultrasonic measurements of subcutaneous adipose tissue and intraabdominal depth: comparisons with skinfold thicknesses.// Int J Obes. 1993. V. 17. P.475−480.
- Bergman RN, Van Citters GW, Mittelman SD, Dea MK, Hamilton-Wessler M, Kim SP, Ellmerer M. Central role of the adipocyte in the metabolic syndrome. J Investig Med. 2001- 49: 119−126.
- Bergmann K.E., Mensink G.B.M. // Gesundheitswesen. 1999. Bd. 61. S. 115—120.
- Berneis KK, Krauss RM. Metabolic origins and clinical significance of LDL heterogeneity. J Lipid Res. 2002- 43: 1363−1379.
- Bhargava A. A longitudinal analysis of the risk factors for diabetes and coronary heart disease in the Framingham Offspring Study. Popul Health Metr. 2003- 1: 3.
- Boden Q., Shulman Q. Free patty acids in obesity and type 2 diabetes: defining the role in the development of insulin resistance and ?-cell dysfunction // Eur. Clin. Fnvest. 2002. Suppl. 3. P. 14—23.
- Boello O., Zamboni M. Visceral obesity and metabolic syndrome. Obesrev, 2000. P. 47—56.
- Borkan GA, Gerzof SG, Robbins AH, Hults DE, Silbert CK, Silbert JE. Assessment of abdominal fat content by computed tomography. // Am J Clin Nutr. 1982. V.36P. 172−177.
- Bray G.A. Clinical evolution and introduction to treatment of overweight / Fn: Contemporary Diagnosis and Management of obesity. 1998. P. 131—166.
- Brochu M, Starling RD, Tchernof A, Matthews DE, Garcia-Rubi E, Poehlman ET. Visceral adipose tissue is an independent correlate of glucose disposal in older obese postmenopausal women. J Cin Endocrinol Metab. 2000- 85: 2378−2384.
- Browning JD, Szczepaniak LS, Dobbins R, Nuremberg P, Horton JD, Cohen JC, Grundy SM, Hobbs HH. Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity. Hepatology. 2004- 40: 1387−1395.
- Brunzell JD. Increased apo B in small dense LDL particles predicts premature coronary artery disease. Arterioscler Thromb Vase Biol. 2005- 25: 474 475.
- Carr MC, Brunzell JD. Abdominal obesity and dyslipidemia in the metabolic syndrome: importance of type 2 diabetes and familial combined hyperlipidemia in coronary artery disease risk. J Clin Endocrinol Metab. 2004−89:2601−2607.
- Casey DE Metabolic issues and cardiovascular disease in patients with psychiatric disorders. Am J Med. 2005- 118 (suppl 2): 15S-22S.
- Chaowalit N, Somers VK, Pellikka PA, Rihal CS, Lopez-Jimenez F. Subepicardial adipose tissue and the presence and severity of coronary artery disease. //Atherosclerosis. 2006. V.186. P.354−359.
- Chen J, Muntner P, Hamm LL, Jones DW, Batuman V, Fonseca V, Whelton PK, He J. The metabolic syndrome and chronic kidney disease in U.S. adults. Ann Intern Med. 2004- 140: 167−174.
- Choi SH, Ahn CW, Cha BS, Chung YS, Lee KW, Lee HC, Huh KB, Kim DJ. The prevalence of the metabolic syndrome in Korean adults: comparison of WHO and NCEP criteria. Yonsei Med J. 2005- 46: 198−205.
- Choudhury J, Sanyal AJ. Clinical aspects of fatty liver disease. Semin Liver Dis. 2004- 24: 349−362.
- Chowdhury B, Kvist H, Andersson B, Bjontorp P, Sjostrom L. CT-determined changes in adipose tissue distribution during a small weight reduction in obese males.// Int J Obes Relat Metab Disord .1993. V. 17 P. 685−691.
- Chowdhury B, Sjostrom L, Alpsten M, Kostanty J, Kvist H, Lofgren. A multicompartment body composition technique based on computorized tomography.// Int J Obes Relat Metab Disord. 1994. V. 18. P. 219−234.
- Cignarelli M, DePergola G, Picca G, et al. Relationship of obesity and body fat distribution with ceruloplasmin serum levels. //Int J Obes. Relat Metab Disord. 1996. V.20 P. 809−813.
- Coughlin SR, Mawdsley L, Mugarza JA Calverley PM, Wilding JP. Obstsructive sleep apnoea is independently associated with an increased prevalence of metabolic syndrome. Eur Heart J. 2004- 25: 735−741.
- Cuspidi C, Meani S, Fusi V, Severgnini B, Valerio C, Catini E, Leonetti G, Magrini F, Zanchetti A. Metabolic syndrome and target organ damage in untreated essential hypertensives. J Hypertens. 2004- 22: 1991−1998.
- Dabela D., Pettitt D.J., Jones K.L., Arslanian S.A. Type 2 diabetes mellitus in mirority children and addlescens. An emerging problem // Endocrinal. metab. clin. Am. 1999. № 28. P. 709—729.
- Chandron, M. Adiponectin: more than just another fat cell hormone? / M. A. Chandron, S. A Phillips, T. Ciaraidi, R. R. Henry // Diabetes Care. 2003. -Vol. 26. — P. 2442—2450.
- Davis J., Goadrich M. The Relationship Between Precision-Recall and ROC Curves // Proc. Of 23 International Conference on Machine Learning, Pittsburgh, PA, 2006
- De Pergola G, Pannacciulli N. Coagulatioin and fibrinolysis abnormalities in obesity. J Endocrinol Invest. 2002- 25: 899−904.
- Derchi LE, Solbiati L, Rizzatto G, De Pra L. Normal anatomy and pathologic changes of the small bowel mesentery: US appearance.// Radiology. 1987. V.164. P. 649−652.
- Demerath E. W., Shen W., Lee M., Choh A.C., Czerwinski S. A., Siervogel R. M., Bradford T.- Approximation of total visceral adipose tissue with a single magnetic resonance image. Obesity.2007- 15:370−376.
- Desperes S., Marette A. Relation of components of insulin resistance syndrome to coronary disease rish // Curr. Opin. Lipid. 1994. V. 5. P. 274—289.
- Despres J-P, Lamarche B. Effects of diet and physical activity on adiposity and body fat distribution: implications for the prevention of cardiovascular disease. //Nutr Res Rev. 1993. V. 6. P. 137−159.
- Despres J-P. Lipoprotein metabolism in visceral obesity.// Int J Obes. 1991. V.15. P.45−5.
- Despres J-P. Obesity and lipid metabolism: relevance of body fat distribution. // Curr Opin Lipidol .1991. V. 2. P.5−15.
- Dietz W.H. Overweight in childhood and odolescence // N. Engl. J. Med. 2004. V. 350 (9). P. 855—857.
- Donnelly L. F, O’Brien K.J., Dardzinski B. J., Poe S.A., Bean J. A. Using a Phantom to Compare MR Techniques for Determining the Ratio of Intraabdominal to Subcutaneous Adipose Tissue. //AJR. 2003. V. 180. P.993−998.
- Duncan GE, Li SM, Zhou XH. Prevalence and trends of a metabolic syndrome phenotype among U.S. adolescents, 1999−2000. Diabetes Care. 2004- 27: 2438−2443.
- Eckel RH, Grundy SM, Zimmet PZ. The metabolic syndrome. Lancet. 2005- 365: 1415−1428.
- Edmunds E., Lip G.Y. Cardiovascular risk in women: the cardiologist perspective // OSM. 2000. V. 93 (3). P. 135—145.
- Enzi G, Gasparo M, Biondetti PR, Fiore D, Semisa M, Zurlo F. Subcutaneous and visceral fat distribution according to sex, age and overweight, evaluated by computed tomography. //Am J Clin Nutr. 1986. V.44. P. 739−746.
- Endocrine, metabolic and nutricional factors in obesity and their relatvy significance an studied by factor analysis / M. Caraulet, F. Perezlemas, F. Y. Tebar, S. Zamora // Int. J. Obesity. 2001. — Vol. 25, № 2. — P. 243—251.
- Fawcett T. ROC Graphs: Notes and Practical Considerations for Researchers // Kluwer Academic Publishers. 2004.
- Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults: findings from the Third National Health and Nutrition Examination Survey. JAMA. 2002- 287: 356−359.
- Ford ES, Giles WH. A comparison of the prevalence of the metabolic syndrome using two proposed definitions. Diabetes Care. 2003- 26: 575−581.
- Foster GD, Wyatt HR, Hill JO, McGuckin BG, Brill C, Mohammed BS, Szapary PO, Rader DJ, Edman JS, Klein S. A randomized trial of a low-carbohydrate diet for obesity. N Engl J Med. 2003- 348: 2082−2090.
- Garg A, Misra A. Lipodystrophies: rare disorders causing metabolic syndrome. Endocrinol Metab Clin North Am. 2004- 33: 305−331.
- Glover GH, Schneider E. Three-point Dixon technique for true water/fat decomposition with B0 field inhomogeneity correction. //Magn Reson Med. 1991. V. 18. P. 371 -383.
- Goodpaster B.H., Thaete F.L., Simoneau J-A., Kelley D.E. Subcutaneous abdominal fat and thigh muscle composition predict insulin sensitivity independently of visceral fat. // Diabetes. 1997. V. 46. P. 1579−1585.
- Grundy SM. Cholesterol gallstones: a fellow traveler with metabolic syndrome? Am J Clin Nutr. 2004- 80: 1−2.
- Grundy SM. Low-density lipoprotein, non-high-density lipoprotein, and apolipoprotein B as targets of lipid-lowering therapy. Circulation. 2002- 106: 2526−2529.
- Haffner SM, Valdez RA, Stern MP, Katz MS 1993 Obesity, body fat distribution and sex hormones in men. Int J Obes 17:634−639
- Gustat J, Srinivasan SR, Elkasabany A, Berenson GS. Relation of self-rated measures of physical activity to multiple risk factors of insulin resistance syndrome in young adults: the Bogalusa Heart Study. J Clin Epidemiol. 2002- 55: 997−1006.
- Hanson RL, Imperatore G, Bennett PH, Knowler WC. Components of the «metabolic syndrome» and incidence of type 2 diabetes. Diabetes. 2002- 51: 31 203 127.
- Hara T, Fujiwara H, Shoji T, Mimura T, Nakao H, Fujimoto S. Decreased plasma adiponectin levels in young obese males. J Atheroscler Thromb. 2003- 10: 234−238.
- Hirooka M, Kumagi T, Kurose K, et al. A technique for the measurement of visceral fat by ultrasonography: comparison of measurements by ultrasonography and computed tomography.//Intern Med. 2005. V.44. P.794−799.
- Hayashi T, Boyko EJ, Leonetti DL, McNeely MJ, Newell-Morris L, Kahn SE, Fujimoto WY. Visceral adiposity is an independent predictor of incident hypertension in Japanese Americans. Ann Intern Med. 2004- 140: 992−1000.
- Hotamisligil GS. Inflammatory pathways and insulin action. Int J Obes Relat Metab Disord. 2003- 27 (suppl 3): S53-S55.
- Hashimoto M, Akishita M, Eto M, et al. The impairment of flow-mediated vasodilatation in obese men with visceral fat accumulation.// Int J Obes Relat. Metab Disord. 1998. V.22. P. 477−484.
- Hu FB, Meigs JB, Li TY, Rifai N, Manson JE. Inflammatory markers and risk of developing type 2 diabetes in women. Diabetes. 2004- 53: 693−700.
- Hube F., Hauner H. The role of TNF alpha in adipocyte tissue: prevention of weight gain at the expense of insulin resistance? // Horm Metab. Res. 1999. № 31. P. 626—631.
- Hunter GR, Snyder SW, Kekes-Szabo T, Nicholson C, Berland I 1994 Intraabdominal adipose tissue variables associated with risk of possessing elevated blood lipids and blood pressure. Obes Res 2:563−569
- Irving B. A., Weltman J.Y., Brock D.W., Davis C.K., Gaesser G. A., Weltman A., NIH ImageJ and Slice-O-Matic Computed Tomography Imaging Software to Quantify Soft Tissue, Circulation. 2006−113:898−918.
- Iacobellis G, Corradi D, Sharma AM. Epicardial adipose tissue: anatomic, biomolecular and clinical relationships with the heart. //Nat Clin Pract. Cardiovasc Med. 2005. V.2.P. 536−543.
- Jaber LA, Brown MB, Hammad A, Zhu Q, Herman WH. The prevalence of the metabolic syndrome among Arab Americans. Diabetes Care. 2004- 27: 234 238.
- Jacobson TA, Case CC, Roberts S, Buckley A, Murtaugh KM, Sung JC, Gause D, Varas C, Ballantyne CM. Characteristics of US adults with the metabolic syndrome and therapeutic implications. Diabetes Obes Metab. 2004- 6: 353−362.
- Jerico C, Knobel H. Montero M, Ordonez-Llanos J, Guelar A, Gimeno JL, Saballs P, Lopez-Colomes JL, Pedro-Botet J. Metabolic syndrome among HIV-infected patients: prevalence, characteristics, and related factors. Diabetes Care. 2005- 28: 132−137.
- Jsozaki O., Tsushima T., Miykawa M. et al. Growth hormone directly inhibits leptin gene expression in visceral fat tissue in fatty Zucker rats // S. Endocrinol. 1999. V. 161. № 3. P. 511—516.
- Juhan-Vague I, Alessi MC, Mavri A, Morange PE. Plasminogen activator inhibitor-1, inflammation, obesity, insulin resistance and vascular risk. J Thromb Haemost. 2003- 1: 1575−1579.
- Juhan-Vague I, Morange PE, Alessi MC. The insulin resistance syndrome: implications for thrombosis and cardiovascular disease. Pathophysiol Haemost Thromb. 2002- 32: 269−273.
- Kannel W.B. Lipids, diabetes and coronary heart disease: insights from the Framingham Study. //Am Heart J .1985. V. 110. P. l 100−1107.
- Kawamoto R, Kajiwara T, Oka Y, Takagi Y. Association between abdominal wall fat index and carotid atherosclerosis in women. J Atheroscler Thromb 2002- 9:213−218
- Kawamoto R, Oka Y, Tomita H, Kodama A, Ootsuka N. Association between abdominal wall fat index on ultrasonography and carotid atherosclerosis in non-obese men.// J Atheroscler Thromb.2005. V. 12. P.85 -91.
- Kawamoto R, Okamoto K. Relation between atherosclerotic risk factors and abdominal wall fat thickness in Japanese. //Nippon Ronen Igakkai Zasshi. 1998. V.35/P. 201−207.
- Kondo I, Mizushige K, Hirao K, et al. Ultrasonographic assessment of coronary flow reserve and abdominal fat in obesity. //Ultrasound Med Biol. 2001. V. 27. P. l 199 -1205.
- Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM, Walker EA, Nathan DM- Diabetes Prevention Program Research Group. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 2002- 346: 393−403.
- Krauss RM, Eckel RH, Howard B, Appel LJ, Daniels SR, Deckelbaum RJ, Erdman JW Jr, Kris-Etherton P, Goldberg IJ, Kotchen TA, Lichtenstein AH, Mitch
- Kris-Etherton PM, Harris WS, Appel LJ- American Heart Association. Nutrition Committee. Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease. Circulation. 2002- 106: 2747−2757.
- Kvist H, Sjostrom L, Tylen U. Adipose tissue volume determinations in women by computed tomography: technical considerations. // Int J Obes. 1986. V. 10. P. 53−67.
- Kuczmarski RJ, Fanelli MT. Ultrasonic assessment of body composition in obese adults: overcoming the limitations of the skinfold caliper. Am J Clin Nutr 1987−45:717−724.
- Laakso M. Gene variants, insulin resistance, and dyslipidaemia. Curr Opin Lipidol. 2004- 15: 115−120.
- Lahti-Koski M, Jousilahti P, Pietinen P. Secular trends in body mass index by birth cohort in eastern Finland from 1972 to 1997. Int J Obes Relat Metab Disord. 2001−25:727−734.
- Lakka HM, Laaksonen DE, Lakka TA, Niskanen LK, Kumpusalo E, Tuomilehto J, Salonen JT. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA. 2002- 288: 2709−2716.
- Larsson H., Elmstahl S., Berglund G. et al. Evidence for leptin regulation in food obstain in humans // Diabetologia. 1998. 41. A 219.
- Lemieux S, Prud’homme D, Bouchard C, Tremblay A, Despres J-P. A single threshold value of waist girth indentifies normal-weight and overweight subjects with excess visceral adipose tissue.// Am J Clin Nutr. 1996. V. 65. P. 685 693.
- Leoncini G, Ratto E, Viazzi F, Vaccaro V, Parodi D, Falqui V, Tomolillo C, Deferrari G, Pontremoli R. Metabolic syndrome is associated with early signs of organ damage in nondiabetic, hypertensive patients. J Intern Med. 2005- 257: 454 460.
- Liao Y, Kwon S, Shaughnessy S, Wallace P, Hutto A, Jenkins AJ, Klein RL, Garvey WT. Critical evaluation of adult treatment panel III criteria in identifying insulin resistance with dyslipidemia. Diabetes Care. 2004- 27: 978−983.
- Liese AD, Hense HW, Doring A, Stieber J, Keil U. Microalbuminuria, central adiposity and hypertension in the non-diabetic urban population of the MONICA Augsburg survey 1994/95. J Hum Hypertens. 2001- 15: 799−804.
- Liu KH, Chan YL, Chan JCN, Chan WB: Association of carotid intima-media thickness with mesenteric, preperitoneal and subcutaneous fat thickness. Atherosclerosis, 2005- 179:299−304
- Liu KH, Chan YL, Chan WB, Chan JC, Chu CW. Mesenteric fat thickness is an independent determinant of metabolic syndrome and identifies subjects with increased carotid intima-media thickness.// Diabetes Care. 2006. V. 29. P. 379 -384.
- Malavazos AE, Ermetici F, Coman C, Corsi MM, Morricone L, Ambrosi B. Influence of epicardial adipose tissue and adipocytokine levels on cardiac abnormalities in visceral obesity.// Int J Cardiol. 2007. V. 121. P. 132 -134.
- Mazurek T, Zhang L, Zalewski A, et al. Human epicardial adipose tissue is a source of inflammatory mediators. //Circulation. 2003. V. 108. P.2460−2466.
- Martin LJ, North KE, Dyer T, Blangero J, Comuzzie AG, Williams J. Phenotypic, genetic, and genome-wide structure in the metabolic syndrome. BMC Genet. 2003- 4 (suppl): S95.
- McGarry S.D., Dobbins R.L. Fatty acids, lipotoxicity and insulin secretion // Diabetologia. 1999. 42. P. 128—138.
- McLaughlin T, Allison G, Abbasi F, Lamendola C, Reaven G. Prevalence of insulin resistance and associated cardiovascular disease risk factors among normal weight, overweight, and obese individuals. Metabolism. 2004- 53: 495−499.
- McNeill AM, Rosamond WD, Girman CJ, Golden SH, Schmidt MI, East HE, Ballantyne CM, Heiss G. The metabolic syndrome and 11-year risk of incident cardiovascular disease in the atherosclerosis risk in communities study. Diabetes Care. 2005- 28: 385−390.
- McNeill AM, Rosamond WD, Girman CJ, Heiss G, Golden SH, Duncan BB, East HE, Ballantyne C. Prevalence of coronary heart disease and carotid arterial thickening in patients with the metabolic syndrome (The ARIC Study). Am J Cardiol. 2004- 94: 1249−1254.
- Merino-Ibarra E, Artieda M, Cenarro A, et al. Ultrasonography for the evaluation of visceral fat and the metabolic syndrome. //Metabolism. 2005. V.54. P.1230−1235.
- Minocci A, Savia G, Lucantoni R, et al. Leptin plasma concentrations are dependent on body fat distribution in obese patients. Hint J Obes. Relat Metab Disord. 2000. V.24. P. 1139−1144.
- Nestler et al. Effects of a reduction in circulating insulin by Metformin on Serum Dehydroepiandrosterone Sulfate in Nondiabetic Men // J. of Clinical Endocr. and Metab. 1994. V. 78. P. 549—554.
- Nesto RW. Correlation between cardiovascular disease and diabetes mellitus: current concepts. Am J Med. 2004- 116 (suppl 5A): 11S-22S.
- Nielsen S, Guo Z, Johnson CM, Hensrud DD, Jensen MD. Splanchnic lipolysis in human obesity. J Clin Invest. 2004- 113: 1582−1588.
- Nilsson P.M. et al. // Hypertens. 1994. V. 12. № 8. P. 965—969.
- Ninomiya JK, L’ltalien G, Criqui MH, Whyte JL, Gamst A, Chen RS. Association of the metabolic syndrome with history of myocardial infarction and stroke in the Third National Health and Nutrition Examination Survey. Circulation. 2004- 109: 42−46.
- Okosun IS, Liao Y, Rotimi CN, Prewitt TE, Cooper RS. Abdominal adiposity and clustering of multiple metabolic syndrome in White, Black and Hispanic Americans. Ann Epidemiol. 2000- 10: 263−270
- Ozsahin AK, Gokcel A, Sezgin N, Akbaba M, Guvener N, Ozisik L, Karademir BM. Prevalence of the metabolic syndrome in a Turkish adult population. Diabetes Nutr Metab. 2004- 17: 230−234.
- Petersen KF, Shulman GI. Pathogenesis of skeletal muscle insulin resistance type 2 diabetes mellitus. Am J Cardiol. 2002- 90: 11G-18G.
- Poll L, Wittsack HJ, Modder U, Heinemann L, Kapitza C, Willers R- Quantification of total abdominal fat volumes using magnetic resonance imaging. Eur J Med Res. 2002- Aug 30−7(8):347−52.
- Poulsen P, Levin K, Petersen I, Christensen K, Beck-Nielsen H, Vaag A. Heritability of insulin secretion, peripheral and hepatic insulin action, and intracellular glucose partitioning in young and old Danish twins. Diabetes. 2005- 54:275−283.
- Radominski RB. The Use of Sonography in the Assessment of Abdominal Fat Distribution. Ph.D. Thesis, Univerity of Sao Paulo Medical School, Sao Paulo, Brazil, 1998.
- Raji A, Seely EW, Arky RA, Simonson DC. Body fat distribution and insulin resistance in healthy Asian Indians and Caucasians. J Clin Endocrinol Metab. 2001- 86: 5366−5371.
- Reaven G. The metabolic syndrome or the insulin resistance syndrome? Different names, different concepts, and different goals. Endocrinol Metab Clin North Am. 2004- 33: 283−303.
- Reaven G.M. Insulin resistance / compensatory hyperinsulinemia, essential hypertension and cardiovascular disease // J. Clin. Endocrinol. Metab. 2003. June. V. 88 (6). P. 2399—2403.
- Ribeiro-Filho FF, Faria AN, Azjen S, Zanella MT, Ferreira SR. Methods of estimation of visceral fat: advantages of ultrasonography. //Obes Res. 2003. V. 11 P.1488 -1494.
- Rissanen P, Makimattila S, Vehmas T, Taavitsainen M, Rissanen A. Effect of weight loss and regional fat distribution on plasma leptin concentration in obese women. //Int J Obes Relat. Metab Disord. 1999. V.23 P. 645 -649.
- Rodriguez A, Muller DC, Engelhardt M, Andres R. Contribution of impaired glucose tolerance in subjects with the metabolic syndrome: Baltimore Longitudinal Study of Aging. Metabolism. 2005- 54: 542−547.
- Roger H. Unger, Yan-Ting Zhou. Lipotoxicity of (3-cells in obesityand in other couses of fatty acid spillover. Birth, life and death of 3cells in type 2 diabetes //Diabetes. 2001. V. 50. Suppl. 1. S. 118—S.121.
- Ross R, Freeman J, Hudson R, Janssen I. Abdominal obesity, muscle composition and insulin resistance in premenopausal women. J Clin Endocrinol Metab. 2002- 87: 5044−5051.
- Ross R, Rissanen J, Hudson R. Sensitivity associated with the identification of visceral adipose tissue levels using waist circumference in men and women: effects of weight loss.// Int J Obes Relat Metab Disord. 1996. V. 20. V. 533 -538.
- Ruan H, Lodish HF. Insulin resistance in adipose tissue: direct and indirect effects of tumor necrosis factor-alpha. Cytokine Growth Factor Rev. 2003- 14: 447−455.
- Ruan H, Lodish HF. Regulation of insulin sensitivity by adipose tissue-derived hormones and inflammatory cytokines. Curr Opin Lipidol. 2004- 15: 297 302.
- Rubins FTB. Triglycerides and coronary heart disease: implications of recent clinical trials. J Cardiovasc Risk. 2000- 7: 339−345.
- Ruel IL, Gaudet D, Perron P, Bergeron J, Julien P, Lamarche B- Quebec LipD Study. Effect of obesity on HDL and LDL particle sizes in carriers of the null
- P207L or defective D9N mutation in the lipoprotein lipase gene: the Quebec LipD Study. Int J Obes Relat Metab Disord. 2003- 27: 631−637.
- Schejbal V. Epicardial fatty tissue of the right ventricle: morphology, morphometry and functional significance in German. //Pneumologie. 1989. V.43. P. 490−499.
- Shulman GI. Cellular mechanisms of insulin resistance. J Clin Invest. 2000- 106: 171−176.
- Sites CK, Calles-Escandon J, Brochu M, Butterfield M, Ashikaga T, Poehlman ET. Relation of regional fat distribution to insulin sensitivity in postmenopausal women. Fertil Steril. 2000- 73: 61−65.
- Sjostrom L. A computed tomography based multicompartment body composition technique and anthropometric predictions of lean body mass, total and subcutaneous adipose tissue. //Int J Obes. 1991. V. 15. P. 19−30.
- Sjostrom L, Kvist H, Cederblad A, Tylen U. Determination of total adipose tissue and body fat in women by computed tomography, 40K and tritium. // Am J Physio. 1986. V. 250. P. 736−745.
- Sjostrom L. Measurement of fat distribution. In: Bouchard C, Johnston FE (eds) Fat Distribution during Growth and Later Health Outcomes. Alan R. Liss, New York, 1988. P. 53−61.
- Sniderman AD. Applying apoB to the diagnosis and therapy of the atherogenic dyslipoproteinemias: a clinical diagnostic algorithm. Curr Opin Lipidol. 2004- 15: 433138.
- Suzuki R, Watanabe S, Hirai Y, et al. Abdominal wall fat index, estimated by ultrasonography, for assessment of the ratio of visceral fat to subcutaneous fat in the abdomen. //Am J Med. 1993.V. 95. P.309 -314.
- Stevens-Simon C, Thureen P, Stamm E, Scherzinger A. A comparison of four techniques for measuring central adiposity in postpartum adolescents. //J Matern Fetal Med. 2001. V. 10. P. 209−213.
- Stolk RP, Meijer R, Mali WP, Grobbee DE, van der Graaf Y. Ultrasound measurements of intraabdominal fat estimate the metabolic syndrome better than do measurements of waist circumference. //Am J Clin Nutr. 2003 .V. 77 P.857 -860.
- Tadokoro N, Murano S, Nishide T, et al. Preperitoneal fat thickness determined by ultrasonography is correlated with coronary stenosis and lipid disorders in non-obese male subjects. //Int J Obes. Relat Metab Disord. 2000. V. 24. P.502 -507.
- Thaete FL, Colberg SR, Burke T, Kelley DE. Reproducibility of computed tomography measurement of visceral adipose tissue area. // Int J Obes. 1995. V. 19. P. 464−467.
- The utility of the international child and adolescent overweight guidelines for predicting coronary heart disease risk factors / P. T. Katzmarzyk, A. Tremblay, L. Pirusse et al. // J. Clin. Epidemiol. 2003. — Vol. 56, № 5. — P. 456—462.
- Tayama K, Inukai T, Shimomura Y. Preperitoneal fat deposition estimated by ultrasonography in patients with non-insulin-dependent diabetes mellitus. //Diabetes Res. Clin Pract. 1999 V.43. P. 49−58.
- Tokunaga K, Matsuzawa Y, Ishikawa K, Tarui S. A novel technique for determination of body fat by computed tomography. // Int J Obes. 1983. V. 7. P. 437−445.
- Tornaghi G, Raiteri R, Pozzato C, Rispoli A, Bramani M, Cipolat M, Craveri A. Anthropometric or ultrasonic measurements in assessment of visceral fat? A comparative study. //Int J Obes. 1994. V. 18. P. 771−775.
- Trayhurn P, Wood IS. Adipokines: inflammation and the pleiotropic role of white adipose tissue. Br J Nutr. 2004- 92: 347−355.
- Turhan H, Yasar AS, Basar N, Bicer A, Erbay AR, Yetkin E. High prevalence of metabolic syndrome among young women with premature coronary artery disease. Coron Artery Dis. 2005- 16: 37−40.
- Van Baak M.A. The peripheral sympathetic nervous system in human obesity // Obesity rev. 2001. V. 3. № 1. P. 3—14.
- Van der Kooy K., Seidell J.C. Techniques for the measurement of visceral fat: a predicted guide. //Int J Obes. Relat Metab Disord. 1993. V.17. P.187−196.
- Weisberg SP, McCann D, Desai M, Rosenbaum M, Leibel RL, Ferrante AW Jr. Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest. 2003- 112: 1796−1808.
- WHO: Obesity: preventing and managing the global epidemic. Report of a WHO consultation of obesity, Geneva, 1997, P. 51−210.
- Wilson P.W., Kannell W.B., Sibershatz H., D’Agostino R.B. Clustering of metabolic factors and coronary heart disease // Arch. Fntern. Med. 1999. V. 159. P. 1104—1109.
- Wilson PW. Estimating cardiovascular disease risk and the metabolic syndrome: a Framingham view. Endocrinol Metab Clin North Am. 2004- 33: 467 481.
- Williams MJ, Hunter GR, Kekes-Szabo T, Treuth MS, Snyder S, Berland L, Blaudeau T 1996 Intra-abdominal adipose tissue cut-points related to elevated cardiovascular risk in women. Int J Obes 20:613−617
- Yamamoto M, Egusa G, Hara H, Yamakido M. Association of intraabdominal fat and carotid atherosclerosis in non-obese middle-aged men with normal glucose tolerance. //Int J Obes. Relat Metab Disord. 1997. V. 21.P.948 -951.
- Zamboni M, Armellini F, Muller D, Sorkin J, Turcato E, Andres R, Bosello O. Methodological and clinical aspects of subcutaneous fat distribution. 1996. V.7. P. 145−150.
- Zweig M.H., Campbell G. ROC Plots: A Fundamental Evaluation Tool in Clinical Medicine // Clinical Chemistry, Vol. 39, No. 4, 1993.